Daniel Bridges

1.8k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Daniel Bridges is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Physiology. According to data from OpenAlex, Daniel Bridges has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Daniel Bridges's work include Neuroscience and Neuropharmacology Research (5 papers), Cannabis and Cannabinoid Research (5 papers) and Pain Mechanisms and Treatments (3 papers). Daniel Bridges is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cannabis and Cannabinoid Research (5 papers) and Pain Mechanisms and Treatments (3 papers). Daniel Bridges collaborates with scholars based in United Kingdom, United States and Switzerland. Daniel Bridges's co-authors include Andrew S.C. Rice, Steve Thompson, Leslie Citrome, J. Winter, Michaela Egertová, Maurice R. Elphick, Wendy P. Battisti, Yvonne E. Yarker, Elizabeth Wager and Karen L. Woolley and has published in prestigious journals such as Annals of Internal Medicine, Neuroscience and British Journal of Pharmacology.

In The Last Decade

Daniel Bridges

10 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

2022 136 citations Lisa DeTora, Fiona J. Plunkett et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Bridges United Kingdom	10	588	520	400	156	132	10	1.3k
Magdalena Kocot-Kępska Poland	17	516 0.9×	335 0.6×	126 0.3×	162 1.0×	92 0.7×	52	1.4k
Chantal Touboul France	9	960 1.6×	501 1.0×	169 0.4×	102 0.7×	82 0.6×	32	1.5k
J Idänpään-Heikkilä Finland	19	372 0.6×	154 0.3×	329 0.8×	167 1.1×	73 0.6×	43	1.2k
Elizabeth J. Rahn United States	17	325 0.6×	476 0.9×	334 0.8×	250 1.6×	36 0.3×	29	1.1k
David Balayssac France	20	495 0.8×	119 0.2×	112 0.3×	241 1.5×	215 1.6×	63	1.6k
Riikka Rontu Finland	25	191 0.3×	143 0.3×	201 0.5×	300 1.9×	48 0.4×	62	1.7k
Dominique Lossignol Belgium	16	185 0.3×	578 1.1×	137 0.3×	107 0.7×	20 0.2×	41	1.3k
So‐Young Jung South Korea	20	255 0.4×	286 0.6×	69 0.2×	179 1.1×	54 0.4×	78	1.6k
Jennifer S. Gewandter United States	24	360 0.6×	245 0.5×	49 0.1×	227 1.5×	56 0.4×	91	1.8k
Karamarie Fecho United States	21	398 0.7×	99 0.2×	407 1.0×	385 2.5×	38 0.3×	58	1.4k

Countries citing papers authored by Daniel Bridges

Since Specialization

Citations

This map shows the geographic impact of Daniel Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bridges more than expected).

Fields of papers citing papers by Daniel Bridges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bridges. The network helps show where Daniel Bridges may publish in the future.

Co-authorship network of co-authors of Daniel Bridges

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bridges. A scholar is included among the top collaborators of Daniel Bridges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bridges. Daniel Bridges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

DeTora, Lisa, Fiona J. Plunkett, Eline E. Hanekamp, et al.. (2022). Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update. Annals of Internal Medicine. 175(9). 1298–1304. 136 indexed citations breakdown →

2.

Battisti, Wendy P., Elizabeth Wager, Daniel Bridges, et al.. (2015). Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine. 163(6). 461–464. 236 indexed citations

3.

Graf, Chris, Wendy P. Battisti, Daniel Bridges, et al.. (2009). Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 339(nov27 1). b4330–b4330. 71 indexed citations

4.

Zhuang, Shou-yuan, et al.. (2005). Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology. 48(8). 1086–1096. 82 indexed citations

5.

Bridges, Daniel, et al.. (2003). Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience. 119(3). 803–812. 141 indexed citations

6.

Brooks, Jason W., Gareth Pryce, Tiziana Bisogno, et al.. (2002). Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors. European Journal of Pharmacology. 439(1-3). 83–92. 68 indexed citations

7.

Grigorenko, Elena, Josef T. Kittler, Chris L. Clayton, et al.. (2002). Assessment of cannabinoid induced gene changes: tolerance and neuroprotection. Chemistry and Physics of Lipids. 121(1-2). 257–266. 34 indexed citations

8.

Bridges, Daniel, et al.. (2001). The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. British Journal of Pharmacology. 133(4). 586–594. 188 indexed citations

9.

Bridges, Daniel, Steve Thompson, & Andrew S.C. Rice. (2001). Mechanisms of neuropathic pain. British Journal of Anaesthesia. 87(1). 12–26. 322 indexed citations

10.

Cork, R. John, et al.. (1998). Chapter 4 A web-accessible digital atlas of the distribution of nitric oxide synthase in the mouse brain. Progress in brain research. 118. 37–50. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact